相关实验视频

Updated: Jul 8, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

卢克索利提尼布在患有APS-1的患者中挽救了多器官临床自身免疫

Romain Lévy^1,2,3,4, Agathe Escudier^5,6, Paul Bastard^7,5,6,8

¹Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, EU, France. romain.levy@inserm.fr.

Journal of clinical immunology

|December 19, 2023

概括

卢克索利提尼布 (Ruxolitinib) 是一种JAK抑制剂,在三名患者中有效治疗了自身免疫多分泌综合征1型 (APS-1),改善了多个器官的表现,具有出色的耐受性. 这表明JAK/STAT通路参与了APS-1病变的发生.

科学领域:

免疫学免疫学免疫学
遗传学是一个遗传学.
药理学药理学是指药理学的学科.

背景情况:

自免疫多分泌综合征类型-1 (APS-1) 由AIRE基因变异引起,导致多器官自身免疫和易受感染.
目前的医疗干预旨在管理自身免疫表现,但针对APS-1的向治疗是有限的.
卢克索利提尼布是一种Janus激酶 (JAK) 抑制剂,用于各种自身免疫性疾病和免疫的先天性错误.

研究的目的:

评估ruxolitinib在治疗APS-1自身免疫表现的疗效和安全性.
探索JAK/STAT通路在APS-1病变发生过程中的潜在作用.

主要方法:

三名患有APS-1的患者接受了至少30个月的ruxolitinib治疗.
监测了临床结果和不良事件.

主要成果:

鲁克索利提尼布在所有三名患者中都表现出良好的耐受性,没有任何不良事件.
在脱发症,指甲发育不良,角膜炎,粘膜类候群病,自身免疫性肝炎,分泌胰腺功能不充分,脏耗,低甲状腺症和无味糖尿病中观察到显著改善.

结论:

鲁克索利提尼布是APS-1患者多种自身免疫表现的有效治疗方法.
这些发现表明,JAK/STAT通路参与了APS-1病变的发生.
在更广泛的APS-1患者队列中进一步研究JAK抑制剂是有必要的.

关键词:

空气中的空气.在APS-1中使用APS-1.雅克抑制剂雅克抑制剂卢克索利提尼布 (Ruxolitinib) 是一种药物.

更多相关视频

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

相关概念视频

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...